000 01382 a2200421 4500
005 20250517150204.0
264 0 _c20180405
008 201804s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-017-2254-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKheloufi, F
245 0 0 _aInformativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cAug 2017
300 _a1009-1018 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xepidemiology
650 0 4 _aFemale
650 0 4 _aFrance
_xepidemiology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPharmacovigilance
650 0 4 _aSelf Report
_xstandards
700 1 _aDefault, A
700 1 _aRouby, F
700 1 _aLaugier-Castellan, D
700 1 _aBoyer, M
700 1 _aRodrigues, B
700 1 _aPonte-Astoul, J
700 1 _aJean-Pastor, M J
700 1 _aBlin, O
700 1 _aMicallef, J
773 0 _tEuropean journal of clinical pharmacology
_gvol. 73
_gno. 8
_gp. 1009-1018
856 4 0 _uhttps://doi.org/10.1007/s00228-017-2254-y
_zAvailable from publisher's website
999 _c27063337
_d27063337